TNFR1 membrane reorganization promotes distinct modes of TNFα signaling.


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
30 07 2019
Historique:
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 15 8 2020
Statut: epublish

Résumé

Signaling by the ubiquitously expressed tumor necrosis factor receptor 1 (TNFR1) after ligand binding plays an essential role in determining whether cells exhibit survival or death. TNFR1 forms distinct signaling complexes that initiate gene expression programs downstream of the transcriptional regulators NFκB and AP-1 and promote different functional outcomes, such as inflammation, apoptosis, and necroptosis. Here, we investigated the ways in which TNFR1 was organized at the plasma membrane at the nanoscale level to elicit different signaling outcomes. We confirmed that TNFR1 forms preassembled clusters at the plasma membrane of adherent cells in the absence of ligand. After trimeric TNFα binding, TNFR1 clusters underwent a conformational change, which promoted lateral mobility, their association with the kinase MEKK1, and activation of the JNK/p38/NFκB pathway. These phenotypes required a minimum of two TNFR1-TNFα contact sites; fewer binding sites resulted in activation of NFκB but not JNK and p38. These data suggest that distinct modes of TNFR1 signaling depend on nanoscale changes in receptor organization.

Identifiants

pubmed: 31363067
pii: 12/592/eaaw2418
doi: 10.1126/scisignal.aaw2418
pii:
doi:

Substances chimiques

NF-kappa B 0
Receptors, Tumor Necrosis Factor, Type I 0
Transcription Factor AP-1 0
Tumor Necrosis Factor-alpha 0
p38 Mitogen-Activated Protein Kinases EC 2.7.11.24
MAP Kinase Kinase Kinase 1 EC 2.7.11.25
MAP3K1 protein, human EC 2.7.11.25
MAP Kinase Kinase 4 EC 2.7.12.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/K015664/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L015773/1
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Penny E Morton (PE)

Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK.

Camille Perrin (C)

Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK.

James Levitt (J)

Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK.

Daniel R Matthews (DR)

Nikon Imaging Centre, King's College London, Hodgkin Building, Guy's Campus, London SE1 1UL, UK.

Richard J Marsh (RJ)

Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK.

Rosemary Pike (R)

Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK.

David McMillan (D)

UCB Celltech, 208 Bath Road, Slough, Berkshire SL1 3WE, UK.

Alison Maloney (A)

UCB Celltech, 208 Bath Road, Slough, Berkshire SL1 3WE, UK.

Simon Poland (S)

Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK.
School of Cancer and Pharmaceutical Sciences, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK.

Simon Ameer-Beg (S)

Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK.
School of Cancer and Pharmaceutical Sciences, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK.

Maddy Parsons (M)

Randall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK. maddy.parsons@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH